A Study Of PF-05212384 Plus FOLFIRI Versus Bevacizumab Plus FOLFIRI In Metastatic Colorectal Cancer

Clinical trial NCT01937715 · TERMINATED

Trial details

NCT number: NCT01937715
Sponsor: Pfizer
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Metastatic Colorectal Carcinoma

Start date: 2014-02-01
Primary completion: 2015-08-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.